BCR and B-cell chronic lymphocytic leukemia: Moreover, in line with the VLA-4 activation data, the ability of BCR triggering to increase VLA-4–mediated CLL cell adhesion observed before treatment was also maintained in CLL cells collected at day 30 of treatment, with no significant difference compared with the pretreatment condition (Fig. 2 C).